DECAF Score for Acute Exacerbation of COPD

ورودی‌های بالینی بیمار

حداقل ۳۵ — حداکثر ۱۲۰ • واحد: years

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
decaf assessment
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–1
  • Intermediate Risk2–2
  • High Risk3–6

Clinical Decision Pathway

Clinical Decision Pathway & Next Steps

Respiratory & Pneumonia — بیماری‌های تنفسی، پنومونی و COPD

Clinical Rationale:

Stratify community-acquired pneumonia with CURB-65 and PSI/PORT; monitor ROX during high-flow oxygen for intubation avoidance, and guide acute COPD exacerbation with BAP-65, DECAF, and GOLD criteria.

← Previous Step in PathwayPrior step

BAP-65 Score for Acute Exacerbation of COPD

امتیاز BAP-65 (تشدید حاد COPD)

Review previous tool

Recommended Clinical Next Steps:

  • Global Initiative for Obstructive Lung Disease (GOLD) Criteria for COPD

    معیارهای GOLD برای شدت COPD

    Why next: Airflow limitation severity staging by post-BD FEV1
Direct Clinical Answer

The DECAF Score for Acute Exacerbation of COPD calculator is designed for bedside predicting in-hospital mortality in acute COPD exacerbation using five clinical variables: Dyspnoea, Eosinopenia, Consolidation, Acidaemia, and atrial Fibrillation in clinical practice. The resulting score directly guides clinician decision-making regarding determining appropriate admission.

Clinical Guidelines & Evidence

Predicts in-hospital mortality in acute COPD exacerbation using five clinical variables: Dyspnoea, Eosinopenia, Consolidation, Acidaemia, and atrial Fibrillation.

Clinical Indication

The DECAF Score for Acute Exacerbation of COPD is indicated for bedside clinical practice to support Predicts in-hospital mortality in acute COPD exacerbation using five clinical variables: Dyspnoea, Eosinopenia, Consolidation, Acidaemia, and atrial Fibrillation.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with community-acquired pneumonia, COPD exacerbations, acute asthma, pulmonary embolism, or acute respiratory distress. Clinical application is indicated across Respiratory care units, emergency pulmonary triage, sleep clinics, and medical floors.

Limitations & Contraindications

Peripheral pulse oximetry loses reliability in hypoperfusion, severe vasoconstriction, methemoglobinemia, or carboxyhemoglobinemia.

Clinical Pearls & Action Plan

Synchronous evaluation of arterial blood gas (PaO2/FiO2), mechanics of breathing, and clinical trajectory guides respiratory failure management.

Formula & Variables:

DECAF Score = Dyspnoea (0-2 points) + Eosinopenia (0-1 point) + Consolidation (0-1 point) + Acidaemia (0-1 point) + atrial Fibrillation (0-1 point)

Input Parameters

NameTypeRequiredDescription
emrcd_dyspneastringYesExtended MRC Dyspnea Scale (eMRCD) - functional status assessment
eosinopeniastringYesEosinopenia (eosinophils <0.05×10⁹/L or <50 cells/μL)
consolidationstringYesConsolidation on chest X-ray
acidemiastringYesAcidemia (arterial blood gas pH <7.30)
atrial_fibrillationstringYesAtrial fibrillation on ECG or history
patient_ageintegerNoPatient age in years (for clinical context, ≥35 years required for score validity)(years)
smoking_historystringNoSmoking history for clinical context (≥10 pack-years required for score validity)

Score Interpretation & Guidance

RangeStageDescription
0–1Low RiskLow mortality risk
2–2Intermediate RiskIntermediate mortality risk
3–6High RiskHigh mortality risk

Evidence-Based References (EBM)

  • Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970-976. doi: 10.1136/thoraxjnl-2012-202103.DOI: 10.1136/thoraxjnl-2012-202103
  • Echevarria C, Steer J, Heslop-Marshall K, et al. Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax. 2016;71(2):133-140. doi: 10.1136/thoraxjnl-2015-207775.DOI: 10.1136/thoraxjnl-2015-207775
  • Zhou M, Chen Y, Yang M, et al. DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMJ Open. 2021;11(2):e044923. doi: 10.1136/bmjopen-2020-044923.DOI: 10.1136/bmjopen-2020-044923
  • Nafae RM, Embarak S, Gad DM. Value of the DECAF score in predicting hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease admitted to Zagazig University Hospitals, Egypt. Egypt J Chest Dis Tuberc. 2015;64(1):35-40. doi: 10.1016/j.ejcdt.2014.07.006.DOI: 10.1016/j.ejcdt.2014.07.006

Related calculators